In last trading session, Transmedics Group Inc (NASDAQ:TMDX) saw 1.41 million shares changing hands with its beta currently measuring 2.11. Company’s recent per share price level of $65.53 trading at -$1.5 or -2.23% at ring of the bell on the day assigns it a market valuation of $2.20B. That closing price of TMDX’s stock is at a discount of -170.67% from its 52-week high price of $177.37 and is indicating a premium of 16.07% from its 52-week low price of $55.00. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 2.07 million shares which gives us an average trading volume of 2.28 million if we extend that period to 3-months.
For Transmedics Group Inc (TMDX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.70. Splitting up the data highlights that, out of 7 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.15 in the current quarter.
Transmedics Group Inc (NASDAQ:TMDX) trade information
Upright in the red during last session for losing -2.23%, in the last five days TMDX remained trading in the green while hitting it’s week-highest on Tuesday, 01/28/25 when the stock touched $65.53 price level, adding 2.34% to its value on the day. Transmedics Group Inc’s shares saw a change of 5.10% in year-to-date performance and have moved 5.74% in past 5-day. Transmedics Group Inc (NASDAQ:TMDX) showed a performance of 4.68% in past 30-days. Number of shares sold short was 8.99 million shares which calculate 3.54 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 109 to the stock, which implies a rise of 39.88% to its current value. Analysts have been projecting 90 as a low price target for the stock while placing it at a high target of 125. It follows that stock’s current price would drop -37.34% in reaching the projected high whereas dropping to the targeted low would mean a loss of -37.34% for stock’s current value.
Transmedics Group Inc (TMDX) estimates and forecasts
Statistics highlight that Transmedics Group Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -52.86% of value to its shares in past 6 months, showing an annual growth rate of 229.87% while that of industry is 14.40. Apart from that, the company came raising its revenue forecast for fiscal year 2025. This year revenue growth is estimated to rise 77.76% from the last financial year’s standing.
8 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 109.49M for the same. And 6 analysts are in estimates of company making revenue of 119.4M in the next quarter. Company posted 81.17M and 96.85M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 8.36% during past 5 years.
Transmedics Group Inc (NASDAQ:TMDX)’s Major holders
Insiders are in possession of 3.21% of company’s total shares while institution are holding 113.40 percent of that, with stock having share float percentage of 117.16%. Investors also watch the number of corporate investors in a company very closely, which is 113.40% institutions for Transmedics Group Inc that are currently holding shares of the company. FMR LLC is the top institutional holder at TMDX for having 4.49 million shares of worth $676.31 million. And as of 2024-06-30, it was holding 13.7063 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 2.65 million shares on 2024-06-30. The number of shares represents firm’s hold over 8.0755 of outstanding shares, having a total worth of $398.47 million.
